Acelyrin, Inc.
SLRN · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | 50% | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -8,287.4% | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -23,109.1% | – | – |
| EPS Diluted | -0.55 | -0.8 | -0.49 | -0.86 |
| % Growth | 31.3% | -63.3% | 43% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |